World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
11311
World Ranking
4045
National Ranking
1846

Kimberly G. Blumenthal publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kimberly G. Blumenthal sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 242 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kimberly G. Blumenthal D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kimberly G. Blumenthal sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kimberly G. Blumenthal is affiliated with Massachusetts General Hospital in the United States and has an extensive research record within the field of Medicine. Their work spans various subfields including Pharmacology, Immunology and Allergy, Dermatology, Infectious Diseases, and Toxicology.

Their research primarily addresses topics such as Drug-Induced Adverse Reactions, Food Allergy and Anaphylaxis Research, Pharmacovigilance and Adverse Drug Reactions, Contact Dermatitis and Allergies, SARS-CoV-2 and COVID-19 Research, Urticaria and Related Conditions, and Allergic Rhinitis and Sensitization.

Kimberly G. Blumenthal has published several research papers, among which the following are notable:

  • Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases, 2021, Journal of the American Academy of Dermatology
  • mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach, 2020, The Journal of Allergy and Clinical Immunology In Practice
  • Drug allergy: A 2022 practice parameter update, 2022, Journal of Allergy and Clinical Immunology
  • Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2, 2021, New England Journal of Medicine
  • Acute Allergic Reactions to mRNA COVID-19 Vaccines, 2021, JAMA

Their frequent co-authors include Aleena Banerji, Elizabeth J. Phillips, Xiaoqing Fu, Upeka Samarakoon, and David A. Khan, reflecting collaborative research efforts within their fields of study.

Frequent publication venues for Kimberly G. Blumenthal's work are:

  • The Journal of Allergy and Clinical Immunology In Practice
  • Journal of Allergy and Clinical Immunology
  • Annals of Allergy Asthma & Immunology
  • Journal of the American Academy of Dermatology
  • New England Journal of Medicine

Best Publications

  • Evaluation and Management of Penicillin Allergy: A Review.

    Erica S. Shenoy;Eric Macy;Theresa Anne Rowe;Kimberly G. Blumenthal

  • Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.

    Devon E. McMahon;Erin Amerson;Misha Rosenbach;Jules B. Lipoff

  • The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk

    Kimberly G Blumenthal;Erin E Ryan;Yu Li;Hang Lee

  • mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.

    Aleena Banerji;Paige G. Wickner;Rebecca Saff;Cosby A. Stone

  • Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study.

    Kimberly G Blumenthal;Na Lu;Yuqing Zhang;Yu Li

  • Drug allergies documented in electronic health records of a large healthcare system

    Li Zhou;Li Zhou;Li Zhou;Neil Dhopeshwarkar;Kimberly G Blumenthal;Foster Goss

  • Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.

    Kimberly G. Blumenthal;Esther E. Freeman;Rebecca R. Saff;Lacey B. Robinson

  • Acute Allergic Reactions to mRNA COVID-19 Vaccines.

    Kimberly G. Blumenthal;Lacey B. Robinson;Carlos A. Camargo;Erica S. Shenoy

  • Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy

    Kimberly G. Blumenthal;Erica S. Shenoy;Christy A. Varughese;Shelley Hurwitz

  • Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs.

    Ana Dioun Broyles;Aleena Banerji;Sara Barmettler;Catherine M. Biggs

  • Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship

    Kimberly G. Blumenthal;Paige G. Wickner;Shelley Hurwitz;Nicholas Pricco

  • Clinical and Pathologic Correlation of Cutaneous COVID-19 Vaccine Reactions including V-REPP: A Registry Based Study.

    Devon E. McMahon;Carrie L. Kovarik;William Damsky;Misha Rosenbach

  • Prevalence of food allergies and intolerances documented in electronic health records

    Warren W. Acker;Joseph M. Plasek;Kimberly G. Blumenthal;Kenneth H. Lai

  • The Cost of Penicillin Allergy Evaluation

    Kimberly G. Blumenthal;Yu Li;Aleena Banerji;Brian J. Yun

  • Drug-Induced Anaphylaxis Documented in Electronic Health Records

    Neil Dhopeshwarkar;Neil Dhopeshwarkar;Aziz Sheikh;Aziz Sheikh;Raymond Doan;Raymond Doan;Maxim Topaz

  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module.

    Anna R. Wolfson;Li Zhou;Yu Li;Neelam A. Phadke

  • First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.

    Anna R. Wolfson;Lacey B. Robinson;Lily Li;Aubree E. McMahon

  • Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record

    Aleena Banerji;Kimberly G. Blumenthal;Kenneth H. Lai;Li Zhou

  • Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience

    Maxim Topaz;Maxim Topaz;Diane L. Seger;Sarah P. Slight;Foster R. Goss

  • Cephalosporin Allergy: Current Understanding and Future Challenges

    David A. Khan;Aleena Banerji;Jonathan A. Bernstein;Basar Bilgicer

  • Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation

    Kimberly G. Blumenthal;Erica S. Shenoy;Anna R. Wolfson;David N. Berkowitz

  • Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America

    Maria Torres;Antonino Romano;G. Celik;P. Demoly

  • Supplemental Appendix for "Cutaneous Reactions Reported after Moderna and Pfizer COVID-19 Vaccination: A Registry-Based Study of 414 Cases"

    Devon McMahon;Erin Amerson;Misha Rosenbach;Jules Lipoff

Frequent Co-Authors

Carlos A. Camargo
Carlos A. Camargo Harvard University
Yuqing Zhang
Yuqing Zhang Harvard University
David W. Bates
David W. Bates Brigham and Women's Hospital
Rochelle P. Walensky
Rochelle P. Walensky Harvard University
Elizabeth J. Phillips
Elizabeth J. Phillips Vanderbilt University Medical Center
David A. Khan
David A. Khan The University of Texas Southwestern Medical Center
Lars E. French
Lars E. French Ludwig-Maximilians-Universität München
Hyon K. Choi
Hyon K. Choi Harvard Medical School
Robert A. Parker
Robert A. Parker Harvard University
João Fonseca
João Fonseca University of Porto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and looking to expand their healthcare expertise, transitioning into nursing specialties can be a rewarding path. Many professionals consider bridging programs such as the fnp to acnp bridge program online to advance their clinical skills and qualify for acute care roles.

Accelerated pathways are popular among candidates eager to fast-track their nursing careers. Programs like accelerated rn to np programs allow registered nurses to quickly gain nurse practitioner qualifications, often with flexible online formats.

Individuals without a nursing background can also find entry points through online nursing programs for non nurses. These programs provide comprehensive learning tailored to those starting fresh in the nursing field, facilitating a smooth transition into healthcare.

For those seeking to earn a Bachelor of Science in Nursing rapidly, 12-month accelerated nursing programs offer an intensive yet accessible route to enter nursing and related immunology careers sooner.

Best Scientists Citing Kimberly G. Blumenthal

Trending Scientists

Recently Published Articles